Director/PDMR Shareholding | 20-May-2025 | 14:49 | RNS |
Medium-term Group guidance ahead of US site visit | 15-May-2025 | 12:00 | RNS |
Director/PDMR Shareholding | 08-May-2025 | 16:35 | RNS |
S&P upgrades Hikma to ‘BBB’ | 08-May-2025 | 10:48 | RNS |
Settlement agreement for Xyrem® US lawsuits | 08-May-2025 | 08:21 | RNS |
Director/PDMR Shareholding | 30-Apr-2025 | 13:21 | RNS |
Result of AGM | 24-Apr-2025 | 15:55 | RNS |
Trading Statement | 24-Apr-2025 | 07:00 | RNS |
Director/PDMR Shareholding | 10-Apr-2025 | 14:36 | RNS |
Director/PDMR Shareholding | 08-Apr-2025 | 13:47 | RNS |
Block listing Interim Review | 01-Apr-2025 | 09:30 | RNS |
Annual Financial Report and Notice of AGM | 19-Mar-2025 | 10:10 | RNS |
Director/PDMR Shareholding | 04-Mar-2025 | 11:16 | RNS |
Final Results | 26-Feb-2025 | 07:00 | RNS |
Notice of Results | 10-Feb-2025 | 08:09 | RNS |
Currency | UK Pounds |
Share Price | 2,076.00p |
Change Today | -2.00p |
% Change | -0.10 % |
52 Week High | 2,340.00 |
52 Week Low | 1,772.00 |
Volume | 390,743 |
Shares Issued | 234.72m |
Market Cap | £4,872.78m |
Beta | 0.00 |
RiskGrade | 125 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 6 |
Buy | 3 |
Neutral | 3 |
Sell | 0 |
Strong Sell | 0 |
Total | 12 |
Latest | Previous | |
---|---|---|
Final | Interim | |
Ex-Div | 20-Mar-25 | 15-Aug-24 |
Paid | 01-May-25 | 20-Sep-24 |
Amount | 48.00¢ | 32.00¢ |
Time | Volume / Share Price |
15:04 | 0 @ 2,072.00p |
14:57 | 0 @ 2,070.00p |
14:57 | 0 @ 2,070.00p |
16:38 | 27,080 @ 2,072.87p |
16:36 | 43,329 @ 2,074.70p |
You are here: research